Genus Capital Management’s Celestica CLS Stock Holding History

Genus Capital Management’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.56M	Sell	20,724 -4,621	-18%	-$1.73M	0.74%	45
2026 Q1	$7.13M	Sell	25,345 -8,528	-25%	-$2.47M	0.82%	42
2025 Q4	$10M	Sell	33,873 -5,725	-14%	-$1.73M	1.17%	27
2025 Q3	$9.75M	Buy	39,598 +11,776	+42%	+$2.37M	1.13%	21
2025 Q2	$4.34M	Buy	27,822 +9,730	+54%	+$1.03M	0.55%	61
2025 Q1	$1.43M	Buy	+18,092	New	+$1.92M	0.21%	107
2024 Q2	–	Sell	-283,606	Closed	-$14.3M	–	231
2024 Q1	$12.8M	Buy	+283,606	New	+$10.8M	1.66%	11
2023 Q4	–	Sell	-140,495	Closed	-$3.74M	–	231
2023 Q3	$3.45M	Buy	140,495 +41,080	+41%	+$841K	0.54%	58
2023 Q2	$1.44M	Buy	+99,415	New	+$1.23M	0.21%	116

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Genus Capital Management's CLS Position: Q2 2026 in Review

Genus Capital Management reduced its Celestica (CLS) stake by 18% in Q2 2026, selling an estimated $1.73M and leaving 20,724 shares worth $7.56M. The position accounts for 0.74% of the portfolio, ranked #45.

Genus Capital Management first reported a position in CLS in Q2 2023 and has held it in 9 quarters since. The position peaked at $12.8M in Q1 2024. 873 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

Genus Capital Management held 20,724 shares of Celestica worth $7.56M as of Q2 2026.
Genus Capital Management sold 4,621 Celestica shares in Q2 2026, an estimated $1.73M.
Celestica made up 0.74% of Genus Capital Management's portfolio in Q2 2026, its #45 holding.
Genus Capital Management first reported a position in Celestica in Q2 2023 and has held it in 9 quarters since.
Genus Capital Management's Celestica position peaked at $12.8M in Q1 2024.
873 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.